Post Operative Atrial Fibrillation

Cardiovascular
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Helios Cardio
Helios CardioMA - Weston
1 program
1
CardiaMend with the Addition of AmiodaronePhase 41 trial
Active Trials
NCT05681182Completed30Est. Feb 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
Helios CardioCardiaMend with the Addition of Amiodarone

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT05681182Helios CardioCardiaMend with the Addition of Amiodarone

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

Start: Jan 2023Est. completion: Feb 202430 patients
Phase 4Completed

Related Jobs in Cardiovascular

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space